Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Go back to Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers| (NASDAQ: GNPX) | Delayed: 0.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.53 | 52 Week High | $ | |||
| Open | $0.53 | 52 Week Low | $ | |||
| Day High | $0.53 | P/E | N/A | |||
| Day Low | $0.53 | EPS | $ | |||
| Volume | 7,688 | |||||
